» Articles » PMID: 35683624

Quality of Life in the First Year After Ischemic Stroke Treated with Acute Revascularization Therapy

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Jun 10
PMID 35683624
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Background: we aimed to describe the disease-specific quality of life (QoL) of ischemic stroke patients treated with acute revascularization therapy, its evolution from 6 months to 12 months, and associated factors. (2) Methods: QoL was assessed with the SS-QoL in consecutive patients treated with either intravenous thrombolysis (IVT) and/or mechanical thrombectomy (MT). Variables associated with QoL scores and its evolution were studied using multivariate mixed models, and interaction with time. Analyses were performed in four domains of SS-QoL: self-care, mobility, mood, and social roles. (3) Results: Among the 501 included patients (mean (sd) age 68.9 (14.5), 49% women), lower post-stroke QoL was independently related to lower level of school education, prestroke mRS > 2, and 24 h NIHSS score > 4. Independent predictors of unfavorable evolution of QoL over time were age <75 years (Mobility p = 0.0194 and Mood p = 0.0015), NIHSS score ≤ 4, (Self-care p = 0.0053 and Mood p = 0.0048), and modified Rankin Scale score ≤ 2 (Social roles, p = 0.0006). Revascularization therapy had no significant effect on the QoL scores, but patients treated with MT (alone or as bridging therapy) had significantly greater improvement in mobility score between 6 and 12 months than patients treated with IVT alone (p = 0.0072). (4) Conclusion: QoL evolution over one year had only slight variation and was associated with the modalities of acute treatment, age, and stroke severity.

Citing Articles

Sex-Related Differences in Post-Stroke Anxiety, Depression and Quality of Life in a Cohort of Smokers.

Suner-Soler R, Maldonado E, Rodrigo-Gil J, Font-Mayolas S, Gras M, Terceno M Brain Sci. 2024; 14(6).

PMID: 38928522 PMC: 11201541. DOI: 10.3390/brainsci14060521.


Long-term functional outcome and quality of life 2.5 years after thrombolysis in acute ischemic stroke.

Schabitz M, Moller L, Friedrich A, Klein N, Kitsiou A, Greeve I Neurol Res Pract. 2023; 5(1):62.

PMID: 37941023 PMC: 10633897. DOI: 10.1186/s42466-023-00291-3.


Symptomatic Intracranial Hemorrhage after Ischemic Stroke Treated with Bridging Revascularization Therapy.

Amaral S, Duloquin G, Bejot Y Life (Basel). 2023; 13(7).

PMID: 37511968 PMC: 10381185. DOI: 10.3390/life13071593.

References
1.
Cael S, Decavel P, Binquet C, Benaim C, Puyraveau M, Chotard M . Stroke impact scale version 2: validation of the French version. Phys Ther. 2014; 95(5):778-90. DOI: 10.2522/ptj.20130012. View

2.
Pontes-Neto O, Silva G, Feitosa M, de Figueiredo N, Fiorot Jr J, Rocha T . Stroke awareness in Brazil: alarming results in a community-based study. Stroke. 2007; 39(2):292-6. DOI: 10.1161/STROKEAHA.107.493908. View

3.
Christensen M, Mayer S, Ferran J . Quality of life after intracerebral hemorrhage: results of the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Stroke. 2009; 40(5):1677-82. DOI: 10.1161/STROKEAHA.108.538967. View

4.
Sturm J, Donnan G, Dewey H, Macdonell R, Gilligan A, Srikanth V . Quality of life after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2004; 35(10):2340-5. DOI: 10.1161/01.STR.0000141977.18520.3b. View

5.
Emberson J, Lees K, Lyden P, Blackwell L, Albers G, Bluhmki E . Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014; 384(9958):1929-35. PMC: 4441266. DOI: 10.1016/S0140-6736(14)60584-5. View